SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

SCHEDULE 13G

(Rule 13d102)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULE 13d1(b) (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d2(b)

 

RELMADA THERAPEUTICS, INC.

(Name of Issuer)

 

COMMON STOCK, $0.001 PAR VALUE PER SHARE

(Title of Class of Securities)

 

75955J 204

(CUSIP Number)

 

Doosik Yi

Chief Executive Officer

Wonpung Mulsan Co., Ltd.

539-3 Gajwa 3-dong

Seo-gu, Incheon, Korea

 

Copies to:

Steven L. Bloch

Bailey & Glasser LLP

One Tower Bridge

100 Front Street Suite 1235

West Conshohocken, PA 19428

 

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

 

June 16, 2016

(Date of Event Which Requires Filing of This Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

  ☐ Rule 13d-1(b)
  ☒ Rule 13d-1(c)
  ☐ Rule 13d-1(d)

 

 

 

  (Page 1 of 4 Pages) 

 

 

CUSIP No. 75955J 204

 

1

 

NAMES OF REPORTING PERSONS

S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

Wonpung Mulsan Co., Ltd.

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                               (a) ☐

                                                                                                                                                (b) ☐

 

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Korea

 NUMBER OF

 SHARES
BENEFICIALLY
OWNED BY
EACH
 REPORTING
PERSON WITH

  5

SOLE VOTING POWER

 

728,000 (1)

 6

SHARED VOTING POWER

 

 7

SOLE DISPOSITIVE POWER

 

728,000 (1)

 8

SHARED DISPOSITIVE POWER

 


9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

728,000 (1)

 10

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)                                                                                                                                                 

 

 11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

6.06% (1)

 12

TYPE OF REPORTING PERSON*

 

CO

       

(1) Based on 12,019,162 shares of Common Stock outstanding as of May 9, 2016.

 

  (Page 2 of 4 Pages) 

 

 

Item 5. Ownership of Five Percent or Less of a Class.

 

Not applicable.

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

 

Not Applicable.

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported by the Parent Holding Company.

 

Not applicable.

 

Item 8. Identification and Classification of Members of the Group.

 

Not applicable.

 

Item 9. Notice of Dissolution of Group.

 

Not applicable.

 

Item 10. Certifications.

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

  (Page 3 of 4 Pages) 

 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Date: June 24, 2016 Wonpung Mulsan Co., Ltd.
     
  By: /s/ Doosik Yi
    Doosik Yi, President and Chief Executive Officer

 

 

(Page 4 of 4 Pages)